Monoclonal Antibody Against ROR1 Induces Apoptosis in Human Bladder Carcinoma Cells

Background: receptor tyrosine kinase-like orphan receptor 1 (ror1) is one of the promising cell surface antigens for targeting cancer cells. the aim of this study was to evaluate ror1 cell surface expression in bladder cancer cells using a murine anti-ror1 monoclonal antibody (mab) called 5f1-b10 as well as investigate its potential in apoptosis induction. methods: expression of ror1 in two human bladder cell lines, 5637 and ej138, as well as a non-cancerous human cell line, human fetal foreskin fibroblast (hfff), was examined by flow cytometry and immunocytochemistry. immunohistochemical staining of cancer and normal bladder tissues was also performed. results: the flow cytometry results showed that 5f1-b10 mab could recognize ror1 molecules in 86.1% and 45.6% of 5637 and ej138 cells, respectively. the expression level of ror1 was 5.49% in hfff cells. the immunocytochemistry and immunohistochemistry staining results also confirmed the presence of ror1 on the surface of both bladder cancer cells and tissues, respectively. the obtained data from apoptosis assay demonstrated that 5f1-b10 mab could induce apoptosis in both 5637 and ej138 cell lines. conclusion: taken together, our finding indicates the role of ror1 in bladder cancer cell survival and suggests this receptor might be a promising target for developing novel therapeutic agents against bladder carcinoma.